jRCT1080220086未知4 期
Post marketing study of sivelestat sodium hydrate for acute lung injury associated with systemic inflammatory response syndrome
ONO PHARMACEUTICAL CO.,LTD.0 个研究点开始时间: 待定
试验速览
- 阶段
- 4 期
- 发起方
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 干预模型
- Open study
入排标准
- 年龄范围
- 18age old over 至 No limit（—）
- 性别
- All
入选标准
- •Male and female patients with ALI associated with SIRS aged over 18 years old are included.
排除标准
- 未提供
结局指标
主要结局
-
Efficacy and safety
次要结局
未报告次要终点
研究者
相似试验
未知
4 期
Post marketing study of sivelestat sodium hydrate for acute lung injury associated with systemic inflammatory response syndromeAcute lung injury (ALI) associated with systemic inflammatory response syndrome (SIRS)JPRN-jRCT1080220086ONO PHARMACEUTICAL CO.,LTD.
已完成
不适用
Sivelestat Sodium Hydrate Treatment for Patients with Kawasaki Disease refractory to initial intravenous immunoglobulin therapyKawasaki DiseaseJPRN-UMIN000013018Department of Pediatrics, Chiba University Hospital45
已完成
3 期
Preventive effect of Sivelestat Na Hydrate on postoperative acute exacerbation of idiopathic interstitial pneumonia in the patient with lung canceridiopathic interstitial pneumonia (IIP)JPRN-UMIN000021109Japanese Northern East Area Thoracic Surgery Study Group (JNETS)120
已完成
2 期
Efficacy of sivelestat sodium administration in perioperative care of abdominal aortic aneurysm with pulmonary function disorderabdominal aortic aneurysmJPRN-UMIN000000650Keio University, School of Medicine Department of Surgery40
已完成
1 期
A pilot study of Elaspol (Sivelestat Sodium) for neuromyelitis opticaneuromyelitis opticaJPRN-UMIN000010094Tohoku University Hospital10